Nanomnia is a biotech SME providing microplastic-free, biodegradable encapsulation services for the agrochemical, cosmetic, pharmaceutical, and advanced materials industries to help firms comply with sustainable EU regulations.
Nanomnia is a biotechnology SME founded in 2017 that specializes in the development of bio-compatible, bio-degradable, and microplastic-free encapsulation technologies. The company designs, synthesizes, and tests organic micro- and nano-formulations for active ingredients, providing solutions that protect against environmental degradation, improve stability and bioavailability, and allow for controlled release. Utilizing a state-of-the-art laboratory equipped with tools such as HPLC, mass spectrometry, and 3D bioprinting, Nanomnia helps clients in the agrochemical, cosmetic, pharmaceutical, nutraceutical, and advanced materials sectors transition away from microplastic additives in compliance with upcoming European regulations. Their R&D and operational model includes licensing registered patents, forming joint ventures, and offering ad-hoc analytical chemistry services to optimize product efficacy and sustainability.
For customers and partners, Nanomnia provides critical support in navigating the transition to sustainable industrial practices by reducing treatment dosages and environmental impact. By encapsulating active principles, the company enables clients to achieve greater specificity in their applications, such as improving the energy conversion efficiency of photovoltaic panels or enhancing the stability of biopesticides. The firm acts as an innovation partner, helping companies test, patent, and bring high-potential, sustainable products to market. Nanomnia has been recognized with numerous industry awards for its agritech and sustainability efforts and continues to collaborate with academic institutions like the University of Verona on advanced biotechnology projects.